The weekly litigation news digest is live. Subscribe now

IP Verse

Use Of Ulipristal Acetate For Treating Uterine Fibroids - EP2684565

The patent EP2684565 was granted to Laboratoire HRA Pharma on Oct 2, 2019. The application was filed on Jan 28, 2009 under application number EP13187859A. The patent is currently recorded with a legal status of "Revoked".

EP2684565

LABORATOIRE HRA PHARMA
Application Number
EP13187859A
Filing Date
Jan 28, 2009
Status
Revoked
May 6, 2022
Publication Date
Oct 2, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
HOFFMANN EITLEJul 2, 2020HOFFMANN EITLEADMISSIBLE
WITTKOPPJul 2, 2020HAMM & WITTKOPPADMISSIBLE

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2005208129
DESCRIPTIONUS4954490
DESCRIPTIONUS5073548
DESCRIPTIONUS5929262
DESCRIPTIONWO2004065405
DESCRIPTIONWO2004078709
OPPOSITIONWO2009095418
SEARCHWO2007038796

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents